Concepedia

Lorenzo Briganti

LB

Statistics

Publications

10

Citations

268

H-Index

10

Active since

2020

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Dana-Farber Cancer Institute

Harvard University

Universidade de São Paulo

Florida State University

Lorenzo Briganti is an author at University of Colorado Anschutz Medical Campus specializing in molecular biology, life sciences, and antiretroviral therapy.

ORCID

Publications per year

2020–2025

10

Publications

10

Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection

Guochao Wei, Naseer Iqbal, Valentine V. Courouble et al. · Nature Communications · 2022 · 59 citations · Full text

, , +17

Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir

S.M. Bester, Daniel Adu‐Ampratwum, Arun S. Annamalai et al. · mBio · 2022 · 50 citations · Full text

, , +17

Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants

Min Li, Dario Oliveira Passos, Zelin Shan et al. · Science Advances · 2023 · 37 citations · Full text

, , +16

Transformation of xylan into value-added biocommodities using Thermobacillus composti GH10 xylanase

Ana Gabriela Veiga Sepulchro, Vanessa O.A. Pellegrini, Lorenzo Briganti et al. · Carbohydrate Polymers · 2020 · 36 citations · Full text

, , +14

The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function

Matthew R. Singer, Tung Dinh, Lev Levintov et al. · mBio · 2023 · 18 citations · Full text

, , +17

1–5 of 10